Showing results (1711-1720 of 1,797) with videos related to

Sort By:
Pageof 180
Blood Neoplasia|June 27, 2025
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experienceMalin Hultcrantz, Andriy Derkach, Hani Hassoun, et al.
Journal of the American College of Cardiology|April 13, 2020
Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic: JACC Review Topic of the WeekChristine J Chung, Tamim M Nazif, Mariusz Wolbinski, et al.
Lupus|June 23, 2011
A retrospective study of pulmonary infarction in patients with systemic lupus erythematosus from southern TaiwanC T Weng, T J Chung, M F Liu, et al.
Blood Cancer Journal|May 27, 2024
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myelomaBruno Almeida Costa, Jessica Flynn, Noriko Nishimura, et al.
Blood Advances|April 15, 2024
Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapiesAnna J Howard, Isabel Concepcion, Alice X Wang, et al.
Diabetes, Obesity & Metabolism|April 23, 2020
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)Gyuri Kim, Soo Lim, Hyuk-Sang Kwon, et al.
Blood|May 10, 2024
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myelomaRoss S Firestone, Nicholas D Socci, Tala Shekarkhand, et al.
American Journal of Hematology|April 3, 2001
Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patientsC W Choi, B S Kim, J H Seo, et al.
American Journal of Hematology|January 2, 2023
Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approachMatthew J Pianko, Timothy Tiutan, Andriy Derkach, et al.
Blood Advances|February 24, 2026
Feasibility of Decentralized Real-World Monitoring of SARS-CoV-2 Booster Vaccines and COVID-19 Outcomes in MyelomaWilliam A Wood, Shaji K Kumar, Emily Semmel, et al.
Pageof 180